source
- STAT+: Five-way obesity drug is super effective — in miceA 'quintuple agonist,' Alector halts it Alzheimer's trial, and more biotech news from The ReadoutSTAT · 3mo ago↗ source
- STAT+: DOJ, Elevance spar over access to top exec in Medicare Advantage fraud caseElevance said a top exec would depart, days after the Justice Department asked to depose him.STAT · 3mo ago↗ source
- Avalyn's upsized IPO; Alector ends another study in GSK partnership🔔 Avalyn Pharma’s $300M IPO: The Boston, MA-based biotech is selling over 16.5 million shares at $18 apiece. The company is set to start trading as {$AVLN} on the Nasdaq Thursday ...Endpoints · 3mo ago↗ source